L. Dau

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen

U. Bredeek, E. Dejesus, H. Khanlou, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines

D. Wohl, J. Rockstroh, Rujuta A. Bam, 2022, ERJ Open Research.

Histologic Evidence of Active Liver Injury in Chronic Hepatitis B Patients With Normal Range or Minimally Elevated Alanine Aminotransferase Levels

William M. Lee, E. Schiff, Z. Goodman, 2010, Journal of clinical gastroenterology.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Renal safety profile of STB in virologically suppressed subjects from two randomized phase 3b switch trials

J. Arribas, M. Fisher, I. Reeves, 2014, Journal of the International AIDS Society.